These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26393058)

  • 21. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.
    Nwe TT; Saw S; Le Win L; Mon MM; van Griensven J; Zhou S; Chinnakali P; Shah S; Thein S; Aung ST
    Infect Dis Poverty; 2017 Sep; 6(1):123. PubMed ID: 28859677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai.
    Udwadia ZF; Moharil G
    Lung India; 2014 Oct; 31(4):336-41. PubMed ID: 25378840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
    Gler MT; Macalintal LE; Raymond L; Guilatco R; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2011 May; 15(5):652-6. PubMed ID: 21756517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production and sales of anti-tuberculosis drugs in China.
    Huang YM; Zhao QP; Ren QM; Peng DL; Guo Y
    Infect Dis Poverty; 2016 Oct; 5(1):88. PubMed ID: 27716386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of scaling up Xpert
    Awan WM; Zaidi SMA; Habib SS; Khowaja S; Malik A; Khan U; Ferrand RA; Creswell J; Khan A
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):899-904. PubMed ID: 29991399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing the private provision of care through premiums for ability: the case of tuberculosis care in the Philippines.
    Quimbo SA
    Health Econ; 2006 Nov; 15(11):1237-44. PubMed ID: 16981188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed.
    Tupasi TE; Quelapio MI; Orillaza RB; Alcantara C; Mira NR; Abeleda MR; Belen VT; Arnisto NM; Rivera AB; Grimaldo ER; Derilo JO; Dimarucut W; Arabit M; Urboda D
    Tuberculosis (Edinb); 2003; 83(1-3):52-8. PubMed ID: 12758189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis control activities in the private and public health sectors of Kenya from 2013 to 2017: how do they compare?
    Mailu EW; Owiti P; Ade S; Harries AD; Manzi M; Omesa E; Kiende P; Macharia S; Mbithi I; Kamene M
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):740-748. PubMed ID: 31334760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaboration between private pharmacies and national tuberculosis programme: an intervention in Bolivia.
    Lambert ML; Delgado R; Michaux G; Vols A; Speybroeck N; Van der Stuyft P
    Trop Med Int Health; 2005 Mar; 10(3):246-50. PubMed ID: 15730509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimate of the global market for rifampicin-containing fixed-dose combination tablets.
    Norval PY; Blomberg B; Kitler ME; Dye C; Spinaci S
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S292-300; discussion S317-21. PubMed ID: 10593708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free drug provision for tuberculosis increases patient follow-ups and successful treatment outcomes in the Indian private sector: a quasi experimental study using propensity score matching.
    Sodhi R; Penkunas MJ; Pal A
    BMC Infect Dis; 2023 Jun; 23(1):421. PubMed ID: 37344775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis services and treatment outcomes in private and public health care facilities in Thailand, 2004-2006.
    Chengsorn N; Bloss E; Anekvorapong R; Anuwatnonthakate A; Wattanaamornkiat W; Komsakorn S; Moolphate S; Limsomboon P; Kaewsa-ard S; Nateniyom S; Kanphukiew A; Varma JK
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):888-94. PubMed ID: 19555540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of tuberculosis care in the private health sector.
    Stallworthy G; Dias HM; Pai M
    J Clin Tuberc Other Mycobact Dis; 2020 Aug; 20():100171. PubMed ID: 32642560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.